scorecardresearch
Thursday, September 4, 2025
TopicCipla

Topic: Cipla

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

Who is Jasdeep Singh Gill, new spiritual head of Punjab’s powerful Dera Beas

An IIT Delhi and Cambridge alumnus, Gill will take over from Gurinder Singh Dhillon. Dera Radha Soami Satsang Beas wields significant influence in Punjab.

Cipla’s US unit recalls 6 bronchospasm inhaler batches over container defect

Cipla advises consumers to discontinue use, return or discard the inhalers, and report any adverse reactions to the U.S. health agency.

Godrej, Cipla, Tata— private archives are filling the gaps in the story of modern India

The National Archives of India has almost no record of India's Green Revolution but National Centre for Biological Sciences in Bangalore does.

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Drugmaker Cipla eyes acquisitions in India, US after Covid windfall

Cipla says it's open to mergers & acquisitions. It may partner with smaller firms working on mRNA platforms after the technology came to the fore during the pandemic.

Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India

Permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future, said NITI Aayog Member Dr V K Paul.

Roche India gets nod for emergency use of Casirivimab, Imdevimab for Covid treatment

The antibody cocktail is to be used for the treatment of mild to moderate Covid in adults and pediatric patients with a high risk of severe symptoms, Roche said in a statement.

Only boycott of British goods won’t do — Why Abdul Hamied went on to create Cipla

In 'Caring For Life: The Cipla Story Since 1935', Tulsi Vatsal writes about how Khwaja Abdul Hamied wanted to create a science-based industry for India.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

On Camera

Why India should let the rupee fall

From Japan in the 1960s to China in the 2000s, many countries transformed their economies by using competitive exchange rates as part of their industrial strategies.

GST 2.0: India streamlines indirect tax regime amid Trump tariffs & what it means for consumers

Goods and Services Tax Council paves way for a broad two-slab structure of 5% and 18% with a demerit rate of 40% for super luxury and 'sin' goods.

‘Loyal wingman’ to full ICBM triad & air defence, China’s show of power at Victory Day parade

China flaunted military might & modernisation as it displayed stealth drones, anti-satellite system & cyber warfare contingent during parade to mark victory over Japan in WWII.

For Indian Mercedes, Asim Munir’s dumper truck in mirror is closer than it appears

From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.